Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-02-03 Sale | 2023-02-07 4:11 pm | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 65,000 | $6.9842 | $453,970 | 5,447,993 (Direct) | View |
| 2023-02-01 Sale | 2023-02-03 4:32 pm | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 90,000 | $7.0833 | $637,500 | 5,512,993 (Direct) | View |
| 2023-01-30 Sale | 2023-02-01 4:07 pm | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 60,000 | $6.995 | $419,700 | 5,602,993 (Direct) | View |
| 2023-01-25 Sale | 2023-01-27 4:17 pm | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 50,000 | $6.85 | $342,500 | 5,662,993 (Direct) | View |
| 2023-01-23 Sale | 2023-01-25 6:17 pm | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 160,000 | $6.895 | $1,103,200 | 5,712,993 (Direct) | View |
| 2023-01-17 Sale | 2023-01-19 4:12 pm | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 6,114 | $6.79 | $41,514 | 5,872,993 (Direct) | View |
| 2023-01-12 Sale | 2023-01-17 4:28 pm | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 6,971 | $6.8774 | $47,943 | 5,879,107 (Direct) | View |
| 2023-01-05 Sale | 2023-01-09 4:08 pm | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 15,162 | $6.9542 | $105,439 | 5,886,078 (Direct) | View |
| 2022-12-29 Sale | 2023-01-05 4:10 pm | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 55,500 | $7.1378 | $396,150 | 5,901,240 (Direct) | View |
| 2022-10-03 Sale | 2022-10-05 4:05 pm | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 32,312 | $8.7836 | $283,815 | 6,076,740 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-01-17 5:09 pm | N/A N/A | Kezar Life Sciences Inc. | KZR | Schiller Mark C. Chief Legal Officer | 0 | $0 | 822,195 (Direct) | View |
| 2024-01-07 Option Award | 2024-01-09 4:57 pm | N/A 2034-01-06 | Kezar Life Sciences Inc. | KZR | Belsky Marc Chief Financial Officer | 295,000 | $0 | 295,000 (Direct) | View |
| 2024-01-07 Option Award | 2024-01-09 4:56 pm | N/A 2034-01-06 | Kezar Life Sciences Inc. | KZR | Mordwinkin Nicholas Michael Chief Business Officer | 275,000 | $0 | 275,000 (Direct) | View |
| 2023-11-08 Option Award | 2023-11-09 4:25 pm | N/A 2033-11-07 | Kezar Life Sciences Inc. | KZR | Kirk Christopher J. CEO | 875,000 | $0 | 875,000 (Direct) | View |
| 2023-08-15 Gift | 2023-08-17 7:08 pm | N/A N/A | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 3,500,000 | $0 | 1,947,993 (Direct) | View |
| 2023-07-24 Option Award | 2023-07-26 5:11 pm | N/A 2031-12-08 | Kezar Life Sciences Inc. | KZR | Wallace Courtney Director | 78,000 | $0 | 78,000 (Direct) | View |
| 2023-07-24 Disposition | 2023-07-26 5:11 pm | N/A 2031-12-08 | Kezar Life Sciences Inc. | KZR | Wallace Courtney Director | 78,000 | $0 | 78,000 (Direct) | View |
| 2023-07-24 Option Award | 2023-07-26 5:10 pm | N/A 2033-01-07 | Kezar Life Sciences Inc. | KZR | Mordwinkin Nicholas Michael Chief Business Officer | 285,000 | $0 | 285,000 (Direct) | View |
| 2023-07-24 Disposition | 2023-07-26 5:10 pm | N/A 2033-01-07 | Kezar Life Sciences Inc. | KZR | Mordwinkin Nicholas Michael Chief Business Officer | 185,000 | $0 | 285,000 (Direct) | View |
| 2023-07-24 Option Award | 2023-07-26 5:08 pm | N/A 2031-05-31 | Kezar Life Sciences Inc. | KZR | Klearman Micki Director | 104,000 | $0 | 104,000 (Direct) | View |
| 2023-07-24 Disposition | 2023-07-26 5:08 pm | N/A 2031-05-31 | Kezar Life Sciences Inc. | KZR | Klearman Micki Director | 104,000 | $0 | 104,000 (Direct) | View |
| 2023-07-24 Option Award | 2023-07-26 5:05 pm | N/A 2029-01-05 | Kezar Life Sciences Inc. | KZR | Kirk Christopher J. Director | 832,500 | $0 | 832,500 (Direct) | View |
| 2023-07-24 Disposition | 2023-07-26 5:05 pm | N/A 2029-01-05 | Kezar Life Sciences Inc. | KZR | Kirk Christopher J. Director | 832,500 | $0 | 832,500 (Direct) | View |
| 2023-07-24 Option Award | 2023-07-26 5:04 pm | N/A 2029-06-24 | Kezar Life Sciences Inc. | KZR | Kauffman Michael Director | 69,792 | $0 | 69,792 (Direct) | View |
| 2023-07-24 Disposition | 2023-07-26 5:04 pm | N/A 2029-06-24 | Kezar Life Sciences Inc. | KZR | Kauffman Michael Director | 69,792 | $0 | 69,792 (Direct) | View |
| 2023-07-24 Option Award | 2023-07-26 5:02 pm | N/A 2030-04-30 | Kezar Life Sciences Inc. | KZR | Henig Noreen Chief Medical Officer | 980,000 | $0 | 980,000 (Direct) | View |
| 2023-07-24 Disposition | 2023-07-26 5:02 pm | N/A 2030-04-30 | Kezar Life Sciences Inc. | KZR | Henig Noreen Chief Medical Officer | 980,000 | $0 | 980,000 (Direct) | View |
| 2023-07-24 Option Award | 2023-07-26 5:01 pm | N/A 2029-12-17 | Kezar Life Sciences Inc. | KZR | Garner Elizabeth Director | 78,689 | $0 | 78,689 (Direct) | View |
| 2023-07-24 Disposition | 2023-07-26 5:01 pm | N/A 2029-12-17 | Kezar Life Sciences Inc. | KZR | Garner Elizabeth Director | 78,689 | $0 | 78,689 (Direct) | View |
| 2023-07-24 Option Award | 2023-07-26 4:59 pm | N/A 2029-01-05 | Kezar Life Sciences Inc. | KZR | Fowler John Franklin CEO | 2,655,000 | $0 | 2,655,000 (Direct) | View |
| 2023-07-24 Disposition | 2023-07-26 4:59 pm | N/A 2029-01-05 | Kezar Life Sciences Inc. | KZR | Fowler John Franklin CEO | 2,655,000 | $0 | 2,655,000 (Direct) | View |
| 2023-07-24 Option Award | 2023-07-26 4:57 pm | N/A 2029-06-24 | Kezar Life Sciences Inc. | KZR | COOPER GRAHAM K Director | 95,792 | $0 | 95,792 (Direct) | View |
| 2023-07-24 Disposition | 2023-07-26 4:57 pm | N/A 2029-06-24 | Kezar Life Sciences Inc. | KZR | COOPER GRAHAM K Director | 95,792 | $0 | 95,792 (Direct) | View |
| 2023-07-24 Option Award | 2023-07-26 4:56 pm | N/A 2031-06-27 | Kezar Life Sciences Inc. | KZR | BERGER FRANKLIN M Director | 52,000 | $0 | 52,000 (Direct) | View |
| 2023-07-24 Disposition | 2023-07-26 4:56 pm | N/A 2031-06-27 | Kezar Life Sciences Inc. | KZR | BERGER FRANKLIN M Director | 52,000 | $0 | 52,000 (Direct) | View |
| 2023-07-24 Option Award | 2023-07-26 4:55 pm | N/A 2029-01-05 | Kezar Life Sciences Inc. | KZR | Belsky Marc Chief Financial Officer | 765,000 | $0 | 765,000 (Direct) | View |
| 2023-07-24 Disposition | 2023-07-26 4:55 pm | N/A 2029-01-05 | Kezar Life Sciences Inc. | KZR | Belsky Marc Chief Financial Officer | 765,000 | $0 | 765,000 (Direct) | View |
| 2023-07-20 Exercise | 2023-07-24 4:20 pm | N/A N/A | Kezar Life Sciences Inc. | KZR | Kirk Christopher J. Director | 48,950 | $0.9 | 505,759 (Direct) | View |
| 2023-07-20 Exercise | 2023-07-24 4:20 pm | N/A 2025-09-09 | Kezar Life Sciences Inc. | KZR | Kirk Christopher J. Director | 48,950 | $0 | 505,759 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:38 pm | N/A 2033-06-14 | Kezar Life Sciences Inc. | KZR | BERGER FRANKLIN M Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:37 pm | N/A 2033-06-14 | Kezar Life Sciences Inc. | KZR | COOPER GRAHAM K Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:37 pm | N/A 2033-06-14 | Kezar Life Sciences Inc. | KZR | Garner Elizabeth Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:36 pm | N/A 2033-06-14 | Kezar Life Sciences Inc. | KZR | Kauffman Michael Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:36 pm | N/A 2033-06-14 | Kezar Life Sciences Inc. | KZR | Wallace Courtney Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:35 pm | N/A 2033-06-14 | Kezar Life Sciences Inc. | KZR | Klearman Micki Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2022-10-18 Ownership | 2023-01-11 4:09 pm | N/A N/A | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 120,000 | $0 | 5,931,740 (Direct) | View |
| 2023-01-08 Option Award | 2023-01-10 4:58 pm | N/A 2033-01-07 | Kezar Life Sciences Inc. | KZR | Mordwinkin Nicholas Michael Chief Business Officer | 185,000 | $0 | 185,000 (Direct) | View |
| 2023-01-08 Option Award | 2023-01-10 4:57 pm | N/A 2033-01-07 | Kezar Life Sciences Inc. | KZR | Kirk Christopher J. President and CSO | 190,000 | $0 | 190,000 (Direct) | View |
| 2023-01-08 Option Award | 2023-01-10 4:56 pm | N/A 2033-01-07 | Kezar Life Sciences Inc. | KZR | Belsky Marc Chief Financial Officer | 195,000 | $0 | 195,000 (Direct) | View |
| 2023-01-08 Option Award | 2023-01-10 4:55 pm | N/A 2033-01-07 | Kezar Life Sciences Inc. | KZR | Fowler John Franklin CEO | 580,000 | $0 | 580,000 (Direct) | View |
| 2023-01-08 Option Award | 2023-01-10 4:55 pm | N/A 2033-01-07 | Kezar Life Sciences Inc. | KZR | Henig Noreen Chief Medical Officer | 220,000 | $0 | 220,000 (Direct) | View |
| 2022-11-10 Exercise | 2022-11-14 08:13 am | N/A N/A | Kezar Life Sciences Inc. | KZR | Fowler John Franklin CEO | 27,000 | $0.9 | 491,836 (Direct) | View |
| 2022-11-10 Exercise | 2022-11-14 08:13 am | N/A 2025-09-09 | Kezar Life Sciences Inc. | KZR | Fowler John Franklin CEO | 27,000 | $0 | 491,836 (Direct) | View |